Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
和鉑醫藥累計斥2.4億元購回股份

2025-04-11T  
《業績》和鉑醫藥全年純利277.8萬美元跌87.8%

2025-03-31T  
和鉑醫藥與AstraZeneca訂戰略合作 溢價發新股籌逾億美元

2025-03-23T  
英藥廠阿斯特捷利康將投資25億美元在北京設立研發中心

2025-03-21T  
和鉑醫藥收到Windward Bio授權協議首付款

2025-03-06T  
和鉑醫藥就治療促皮質素釋放激素醫藥產品授出全球獨家授權

2025-02-26T  
和鉑與英矽智能締戰略合作 拓AI驅動抗體藥物研發

2025-02-20T  
和鉑醫藥料年度溢利介乎730萬至2,200萬元人民幣

2025-02-14T  
和鉑醫藥上周五回購1,000萬股

2025-02-10T  
和鉑醫藥治療慢性阻塞性肺病藥獲批臨床

2025-02-05T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.